GATEIO EXCHANGE RANKING

BRAF — a tumour-agnostic drug target with lineage-specific dependencies

Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization

Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling

An oncogenic enhancer encodes selective selenium dependency in AML